Parnax Lab Limited share price
NSE: PARNAXLAB · ISIN INE383L01019
Key numbers
- Market cap
- -
- Current price
- ₹ 118.22
- 52-week high / low
- ₹ 150 / 104
- Stock P/E
- 15.2
- Book value
- ₹ 83.1
- Dividend yield
- 0.00%
- ROCE
- 13.0%
- ROE
- 13.2%
- Debt to equity
- 0.87
- Sales growth (3 yrs)
- 14.0%
- Profit growth (3 yrs)
- 11.0%
- 1-year return
- -
About Parnax Lab Limited
Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic; herbal; and nutraceutical products. It also provides oral formulations, such as cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provides drug identification and development services; in- and out-licensing services; and contract research and manufacturing services. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. Parnax Lab Limited was incorporated in 1982 and is headquartered in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 53 | 63 | 63 | 70 | 57 |
| Operating profit | 7 | 8 | 7 | 5 | 4 |
| Net profit | 3 | 4 | 3 | 2 | 0 |
| EPS (₹) | 2.85 | 3.15 | 2.37 | 1.90 | 0.37 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.